Bowman Peter R T, Smith Godfrey L, Gould Gwyn W
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
PeerJ. 2021 May 25;9:e11485. doi: 10.7717/peerj.11485. eCollection 2021.
The global incidence, associated mortality rates and economic burden of diabetes are now such that it is considered one of the most pressing worldwide public health challenges. Considerable research is now devoted to better understanding the mechanisms underlying the onset and progression of this disease, with an ultimate aim of improving the array of available preventive and therapeutic interventions. One area of particular unmet clinical need is the significantly elevated rate of cardiomyopathy in diabetic patients, which in part contributes to cardiovascular disease being the primary cause of premature death in this population. This review will first consider the role of metabolism and more specifically the insulin sensitive glucose transporter GLUT4 in diabetic cardiac disease, before addressing how we may use exercise to intervene in order to beneficially impact key functional clinical outcomes.
糖尿病的全球发病率、相关死亡率和经济负担已使其成为全球最紧迫的公共卫生挑战之一。目前,大量研究致力于更好地理解该疾病发生和发展的潜在机制,最终目标是改善现有的预防和治疗干预措施。糖尿病患者中心肌病发生率显著升高,这在一定程度上导致心血管疾病成为该人群过早死亡的主要原因,这是一个特别未得到满足的临床需求领域。本综述首先将探讨代谢的作用,更具体地说是胰岛素敏感性葡萄糖转运蛋白GLUT4在糖尿病性心脏病中的作用,然后讨论如何通过运动进行干预,从而对关键的功能性临床结局产生有益影响。